Skip to Content
(UB)
Jacobs School of Medicine and Biomedical Sciences
University at Buffalo (UB)
Jacobs School of Medicine and Biomedical Sciences
Department of Pharmacology and Toxicology
Apply
Toggle Navigation Menu
4/1/21
About Us
6/19/14
Education
11/10/21
Faculty
8/13/24
Research and Facilities
6/19/14
News and Events
4/1/21
About Us
6/19/14
Education
11/10/21
Faculty
8/13/24
Research and Facilities
6/19/14
News and Events
Search
Info For
Info For
Current Students
Apply
Pharmacology and Toxicology
>
Research and Facilities
>
Recent Faculty Publications
Research and Facilities
Areas of Research
Recent Faculty Publications
Recent Research Funding
Researcher Spotlight
Collaborative Research
Research Centers
Core Facilities
Departmental Research Facilities
Faculty/Staff Intranet
Recent Faculty Publications
Finnell JE, Ferrario CR. (2025)
Voluntary food restriction does not affect circulating corticosterone in obesity-prone or -resistant male and female rats.
Physiology & behavior (Jan), 288: 114729.
Lu H, Roeder N, Richardson B, Hamilton J, Sharma A, Owada Y, Kagawa Y, Thanos P. (2025)
Fatty acid-binding protein 7 gene deletion promotes decreases in brain cannabinoid type 1 receptor binding.
Neuroscience letters (Jan), 844: 138040.
Sharafshah A, Lewandrowski KU, Gold MS, Fuehrlein B, Ashford JW, Thanos PK, Wang GJ, Hanna C, Cadet JL, Gardner EL, Khalsa JH, Braverman ER, Baron D, Elman I, Dennen CA, Bowirrat A, Pinhasov A, Modestino EJ, Carney PR, Cortese R, Fiorelli RKA, Schmidt S, Pollack AR, Badgaiyan RD, Blum K. (2025)
In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicide Ideation and Substance Use Disorder.
Current neuropharmacology (Jan).
Green RP, Blum K, Lewandrowski KU, Gold MS, Lewandrowski APL, Thanos PK, Dennen CA, Baron D, Elman I, Sharafshah A, Modestino EJ, Badgaiyan RD. (2025) Letter to the Editor.
Response to the SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk.
Substance abuse and rehabilitation (Jan), 16: 23-26. doi:10.2147/SAR.S514931
Sunder K, Makale MT, Makale M, Bodhanapati J, Murphy KT, Dennen CA, Baron D, Thanos PK, Hanna C, Ashford JW, Lewandrowski KU, Blum K. (2025)
Coupling Bio-Resonance Neurotechnology (BRNT) and Dual Hemispheric Repetitive Transcranial Magnetic Stimulation (rTMS) Reduces Comorbid Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) as Demonstrated by PHQ-9 and GAD-7: Pilot Case Series.
Psychology research and behavior management (Jan), 18: 225-240. doi:10.2147/PRBM.S482960
Blum K, Bowirrat A, Thanos PK, Hanna C, Khalsa J, Baron D, Elman I, Badgaiyan RD, Dennen C, Braverman ER, Carney P, Lewandrowski KU, Sharafshah A, Gold MS. (2024)
Evidence Based Clinical Analytics Supporting the Genetic Addiction Risk Severity (GARS) Assessment to Early Identify Probands in Preaddiction.
EC psychology and psychiatry (Dec), 13(1): 1-3.
Lewter LA, Woodhouse K, Tiruveedhula VVNPB, Cook JM, Li JX. (2024)
Antinociceptive Effects of a2/a3-Subtype-Selective GABAA Receptor Positive Allosteric Modulators KRM-II-81 and NS16085 in Male Rats: Behavioral Specificity.
The Journal of pharmacology and experimental therapeutics (Nov), 391(3): 389-398. doi:10.1124/jpet.123.002070
Costa PC, Salinas B, Wojciechowski A, Wood SK, Runyon S, Clark SD. (2024)
The Influence of the Estrous Cycle on Neuropeptide S Receptor-Mediated Behaviors.
The Journal of pharmacology and experimental therapeutics (Nov), 391(3): 460-471. doi:10.1124/jpet.124.002415
Martin MK, Rodriguez R, Guerrero G, Sheehan GD, Powell R, Klein AH, Bhattacharjee A. (2024)
Pharmacologically enabling the degradation of NaV1.8 channels to reduce neuropathic pain.
Pain (Nov).
Molly K Martin MK, Rodriguez R, Guerrero G, Sheehan GD, Powell R, Klein AH, Bhattacharjee A. (2024)
Pharmacologically enabling the degradation of NaV1.8 channels to reduce neuropathic pain.
Pain (Nov) doi:10.1097/j.pain.0000000000003470
Hrabak M, Ahmed R, Soriano MG, Powell A, Thanos PK, Steiner H. (2024)
Correction: Vilazodone, a Novel SSRI Antidepressant with 5-HT1A Partial Agonist Properties: Diminished Potentiation of Chronic Oral Methylphenidate-Induced Dynorphin Expression in the Striatum in Adolescent Male Rats.
Peng L, Zhang J, Feng J, Ge J, Zou Y, Chen Y, Xu L, Zeng Y, Li JX, Liu J. (2024)
Activation of trace amine-associated receptor 1 ameliorates PTSD-like symptoms.
Biochemical pharmacology (Oct), 228: 116236.
Collins RL, Thanos PK, Ashare R, Herzberg D, Silverman R. (2024)
Effects of the Federal Government's Move to Reschedule Cannabis: A Commentary.
Journal of studies on alcohol and drugs (Oct).
Cooper JJM, Muthaiah R, Frost JR, Buck GT, Ravichandar R, Gadelkarim F, Raymond FD, Sim FJ. (2024)
Clemastine Induces Oligodendrocyte Progenitor Pool Exhaustion and Senescence in the Context of Chronic Demyelination in a Rabbit Model.
Annals of neurology (Oct).
Hrabak M, Ahmed R, Soriano MG, Powell A, Thanos PK, Steiner H. (2024)
Vilazodone, a Novel SSRI Antidepressant with 5-HT1A Partial Agonist Properties: Diminished Potentiation of Chronic Oral Methylphenidate-Induced Dynorphin Expression in the Striatum in Adolescent Male Rats.
Molecular neurobiology (Oct).
Penman SL, Roeder NM, Wang J, Richardson BJ, Pareek O, Freeman-Striegel L, Mohr P, Khan A, Eiden RD, Chakraborty S, Thanos PK. (2024)
Vaporized nicotine in utero results in reduced birthweight, increased locomotion, and decreased voluntary exercise, dependent on sex and diet in offspring.
Psychopharmacology (Sep), 241(9): 1857-1882.
Penman SL, Roeder NM, Wang J, Richardson BJ, Freeman-Striegel L, Krayevsky A, Eiden RD, Chakraborty S, Thanos PK. (2024)
Vaporized ?9-tetrahydrocannabinol exposure in utero has negative effects on attention in a dose- and sex-dependent manner.
Pharmacology, biochemistry, and behavior (Sep), 242: 173808.
Smith Z, Cheli VT, Angeliu CG, Wang C, Denaroso GE, Tumuluri SG, Corral J, Garbarini K, Paez PM. (2024)
Ferritin loss in astrocytes reduces spinal cord oxidative stress and demyelination in the experimental autoimmune encephalomyelitis (EAE) model.
Glia (Sep).
Blum K, Elman I, Han D, Hanna C, Baron D, Gupta A, Kazmi S, Khalsa J, Bagchi D, McLaughlin T, Badgaiyan RD, Modestino EJ, Edwards D, Dennen CA, Braverman ER, Bowirrat A, Sunder K, Murphy K, Jafari N, Zeine F, Carney PR, Gold MS, Lewandowski KU, Sharafshah A, Pollack AR, Thanos PK. (2024)
The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial Therapies.
Open journal of immunology (Sep), 14(3): 60-86. doi:10.4236/oji.2024.143006
Fisher C, Johnson K, Moore M, Sadrati A, Janecek JL, Graham ML, Klein AH. (2024)
Loss of ATP-Sensitive Potassium Channel Expression and Function in the Nervous System Decreases Opioid Sensitivity in a High-Fat Diet-Fed Mouse Model of Diet-Induced Obesity.
Diabetes (Aug), 73(8): 1244-1254. doi:10.2337/db23-1030